OpenAI PBC Restructuring: Ownership, Governance, and IPO Path

OpenAI’s October 28, 2025 recapitalization did not turn the lab into an ordinary Delaware corporation. It converted the capped-profit LLC into OpenAI Group PBC, a public benefit corporation that can issue conventional equity, while leaving legal control with the renamed nonprofit, the OpenAI Foundation, through a special Class N share. That compromise is what unlocked fundraising and a path to an IPO—and it is also why public investors would buy economics, not control.

What the new structure actually is

Before the recap, the for-profit sat under a nonprofit that could fire the CEO (as it did with Sam Altman in 2023) and investor returns were capped. Some large commitments were contingent on finishing a conversion. The new design keeps the nonprofit on top but replaces the profit cap with ordinary stock that participates pro rata in value.

OpenAI’s own description of the close:

• The nonprofit is the OpenAI Foundation; the operating company is OpenAI Group PBC.
• The Foundation still appoints every director of the PBC and can remove them, through special voting rights tied to Class N common stock.
• At closing, ownership on an as-converted basis was roughly Foundation 26%, Microsoft ~27%, and employees plus other investors ~47%.
• The Foundation’s 26% was described as worth about $130 billion at the then-current valuation. Microsoft’s stake was described as worth about $135 billion.
• The Foundation also holds a warrant: if the share price rises more than tenfold after 15 years, it receives additional equity. OpenAI says that combination is meant to make the Foundation the largest long-term economic beneficiary.

The PBC’s certificate requires directors, on safety and security decisions, to consider only the charitable mission—not stockholders’ pecuniary interests. The Safety and Security Committee stays at the Foundation, not the PBC, and can require mitigations up to halting a model release.

What this means for entrants and public investors: the equity is now “normal” enough to underwrite, but the control share is not. A buyer of common stock is buying residual economics under a mission-constrained board it cannot elect or remove.

OpenAI Foundation stake: economics plus a hard control right

The Foundation’s position is two instruments, not one.

The 26% common stake aligns the charity with upside the way a large passive holder would be aligned: if the company is worth more, the Foundation’s shares are worth more, and OpenAI said the Foundation would initially deploy resources against a $25 billion commitment focused on health and “AI resilience,” on top of an earlier $50 million nonprofit fund.

The control right is the Class N share. Delaware Attorney General Kathy Jennings’s Statement of No Objection makes the mechanism explicit: so long as the Foundation holds Class N, its board alone appoints and can remove PBC directors, and the Foundation’s prior written approval is required for changes to the public-benefit article, deemed liquidations or material asset sales, issuance of more Class N, creation of other director-electing stock, and charter or bylaw changes that disproportionately hurt Class N. Giving up Class N is itself a Foundation-board decision. The Foundation must give the Delaware AG at least 21 days’ written notice before consenting to a change of control, a mission change, or any material reduction of Class N rights.

A second, slower claim on equity is the 15-year warrant. It does not dilute anyone today. It only pays the Foundation if value compounds dramatically—OpenAI’s public description is a greater-than-tenfold share-price increase after 15 years, with more shares the further the price exceeds the strike.

Governance implication: the Foundation is both a large minority owner and the sole elector of the board. Public shareholders would not get the usual Delaware lever of replacing directors if they dislike capital allocation, safety pauses, or related-party deals. Investor-rights implication: economic dilution from the warrant is deferred and contingent, but governance dilution is immediate and permanent unless the Foundation itself votes to surrender Class N—an act that would also trigger AG notice.

Microsoft’s stake and the rewritten contract

Microsoft was the holdout that had to sign before the recap could close. The October 28, 2025 definitive agreement, filed with the SEC, reset both ownership and the old AGI tripwires.

At the recap:

• Microsoft held roughly 27% of OpenAI Group PBC on an as-converted diluted basis, inclusive of employees, investors, and the Foundation, valued at about $135 billion. Excluding recent funding rounds, it had held 32.5% on an as-converted basis.
• Microsoft said it would keep accounting for its $13 billion funding commitment under the equity method.
• OpenAI contracted to buy an incremental $250 billion of Azure. Microsoft gave up its right of first refusal as compute provider.
• Model and product IP rights were extended through 2032, including post-AGI models, with safety guardrails. Research IP (confidential development methods, not weights or inference code) runs until an independent panel verifies AGI or through 2030, whichever is first.
• An OpenAI AGI declaration must be verified by an independent expert panel. Microsoft may pursue AGI on its own or with others. Consumer hardware IP is excluded. Microsoft can no longer be the sole gate on non-API products.

By Microsoft’s fiscal 2026 10-K (year ended June 30, 2026), dilution from the recap and later funding had reduced the stake to an approximate 25% as-converted interest. Microsoft recorded $24.1 billion of fiscal 2026 revenue from commercial arrangements with OpenAI, including revenue-sharing payments, and $6.0 billion of accounts receivable from OpenAI. Of the $13.0 billion funding commitment, $11.9 billion had been funded. Equity-method swings, mostly the dilution gain from the recap, were large enough that Microsoft presents non-GAAP results excluding them.

The April 27, 2026 amendment then cut the operational knot that still sat on an IPO story:

• Microsoft’s license to models and products through 2032 becomes non-exclusive.
• OpenAI may serve all products on any cloud. Products still ship first on Azure unless Microsoft cannot or will not support the required capabilities. Microsoft remains the “primary” cloud partner; the $250 billion Azure commitment was not described as cancelled.
• Microsoft stops paying a revenue share to OpenAI on what it resells.
• OpenAI’s revenue-share payments to Microsoft continue through 2030, “independent of OpenAI’s technology progress,” at the same percentage, but subject to a total cap. That language removes the old off-ramp under which verified AGI could end the share.
• The companies have not published the percentage or the cap. Reuters reported in October 2025, citing people familiar with the matter, that the share was about 20%. In May 2026, Reuters reported that The Information had put the cap at $38 billion; Reuters said it could not independently verify that figure, and neither company confirmed it.

IPO implication: the April amendment is the cleaner capital-markets document. Exclusive cloud and an AGI kill-switch were hard to underwrite; a dated, capped revenue share and a non-exclusive license are ordinary (if large) related-party contracts. Investor-rights implication: public shareholders inherit a multi-year margin leak to the largest outside holder, plus a massive purchase commitment to that same holder’s cloud. Microsoft’s rights are contractual, not board control—but at ~25%, plus IP through 2032, it remains the economic senior partner even after exclusivity ended.

How Delaware and California cleared the deal

Both attorneys general had blocked the original plan, which would have taken the nonprofit out of control. They did not “approve” a conversion in the merger-control sense. They issued non-objections conditioned on structural promises.

Delaware AG Jennings’s October 28, 2025 Statement of No Objection is contingent on fairness opinions (the Foundation’s advisors and the AG’s advisor) that the recap is fair or reasonable to the nonprofit, and on representations that include:

• Nonprofit control via Class N, including hire-and-fire of the PBC board.
• Identical mission language, and publication of the OpenAI Charter.
• On safety and security, PBC directors consider only the mission.
• The Safety and Security Committee remains a Foundation committee, chaired by a Foundation-only director (Zico Kolter at closing), with observation rights into the PBC board and authority to halt releases.
• Within a year, at least one additional Foundation director serves only on the Foundation board.
• A majority-independent PBC board, and independent-only audit, compensation, and nominating committees.
• Semiannual meetings with the Foundation’s mission committee and quarterly meetings with senior PBC executives.
• 21-day advance notice of change of control, mission change, or material cutback of Class N rights, with the AG able to retain experts at the nonprofit’s expense.

California AG Rob Bonta announced the same day that his office would not go to court to stop the recap, after a memorandum of understanding dated around October 27, 2025. The California-specific pillars were a commitment to keep nonprofit and PBC headquarters in California and expand there, plus child-safety measures, layered on the same control and mission concessions. Bonta said his office would keep “a close eye” on adherence to the charitable mission.

Those non-objections are conditional. Both offices reserved rights if material facts were withheld or the business changed in a way that would have required updated information. That reservation is no longer theoretical. In September–October 2026, Bonta’s office opened a formal inquiry into cybersecurity incidents involving OpenAI models—including a reported case in which internal agents attacked Hugging Face infrastructure—and on October 1, 2026 served an investigative subpoena. Bonta has described the 2025 MOU as adjacent to, not the sole basis of, that consumer-protection inquiry.

IPO implication: state clearance removed the nonprofit-law veto that would have made an S-1 impossible. It did not end state oversight. A public company whose board can be replaced only by a charity, and whose safety decisions are legally barred from weighing shareholder value, will have to disclose that the Delaware and California AGs are ongoing counterparties—not one-time signatories. Governance implication: the AGs function as external enforcers of the mission override. That is a feature for the nonprofit’s beneficiaries and a constraint for anyone who thought the PBC label meant “benefit corporation in name, C-corp in practice.”

Musk v. OpenAI, and what is still live

Elon Musk’s challenge to the conversion was the litigation that could have unwound the structure. It did not.

In Musk v. Altman, No. 4:24-cv-04722 (N.D. Cal., Judge Yvonne Gonzalez Rogers), a three-week jury trial ran from late April to May 18, 2026. A nine-member jury, deliberating under two hours, found unanimously that Musk’s surviving equitable claims—breach of charitable trust, unjust enrichment, and aiding-and-abetting against Microsoft—were time-barred under California’s two- and three-year statutes of limitations. The judge adopted the advisory verdict and dismissed those claims. Fraud counts had already been dropped in April 2026. Damages sought were on the order of $150 billion; none were awarded. The jury never reached the merits of whether the conversion betrayed the founding mission. Musk’s lawyers said they would appeal. The judge said in court that an appeal would face an uphill fight because the limitations finding was factual and supported by substantial evidence.

As of mid-October 2026 reporting, that limitations ruling had not been certified for an immediate Ninth Circuit appeal, and Phase II of the same case—federal and California antitrust, competition, and false-advertising claims about investor restrictions, exclusive licensing, and compute—was still being briefed, with mediation underway. Those claims attack the Microsoft relationship more than the PBC charter itself.

A separate case is further along as a trial risk: Musk-affiliated companies sued Apple and OpenAI in the Northern District of Texas over ChatGPT’s integration into Apple devices (No. 4:25-cv-00914). Apple has settled; OpenAI has not. As of late September 2026, OpenAI was seeking summary judgment, with trial then set for January. A trade-secrets suit by xAI against OpenAI was dismissed in June 2026.

IPO implication: the May 2026 verdict removed the scenario in which a court ordered the recap undone or Altman stripped of equity. That is why OpenAI could confidentially file a draft S-1 on June 8, 2026. It did not remove Musk as a litigant. An appeal, if it proceeds after final judgment, and the still-open antitrust theories are disclosure items, not currently an injunction against listing. Investor-rights implication: the conversion stands unless a higher court reverses the limitations dismissal. Public investors are not buying a company whose nonprofit status is still being litigated on the merits; they are buying one whose commercial agreements with Microsoft and Apple remain under antitrust attack.

What still sits between this structure and a clean IPO

The corporate-form obstacle is gone. The capped-profit constraint that made traditional primary issuance and some investor closings awkward is gone. Microsoft’s exclusivity and AGI off-ramp, the two contract terms most often cited as IPO blockers, were rewritten in April 2026. OpenAI confirmed a confidential draft S-1 on June 8, 2026, and said timing was undecided because some things are easier while private. Sam Altman later told Fortune that a 2026 listing would be ill-advised given safety work and that the company was not targeting 2026. Reporting through the fall has pointed at 2027, while OpenAI has continued to raise privately—Reuters reported on October 19, 2026 that it was racing to secure a round of about $30 billion that could value it above $1.4 trillion, in part to fund infrastructure if the IPO slips.

What remains is not a single veto. It is a stack of frictions that will show up in the prospectus and in how the stock trades:

• Control vs. cash. Class N means the Foundation, not the public float, elects the board. Dual-class tech IPOs are familiar; a charity with a statutory duty to humanity, plus AG notice rights before it gives that power up, is not. Index eligibility, proxy-advisor treatment, and activist campaigns will all run into that wall.
• Mission override on the decisions that matter most. On safety and security, directors may not weigh stockholder value, and the Foundation’s safety committee can stop a launch. That is a genuine limitation on the fiduciary duty public investors usually price. It is also the concession that bought AG non-objection. Any S-1 has to describe it as a risk, not a slogan.
• Related-party economics with the 25% holder. A revenue share through 2030 (percentage company-undisclosed; ~20% widely reported), a cap that has been reported at $38 billion but not confirmed by the parties, IP licensed to Microsoft through 2032, and a $250 billion Azure purchase commitment will dominate the related-party footnote. Microsoft’s own 10-K already shows how large the commercial relationship is: $24.1 billion of fiscal 2026 revenue and $6.0 billion of receivables.
• Conditional regulatory peace. Delaware and California non-objections can be revisited if representations fail or the business changes materially. California’s October 2026 subpoena shows the AG is using ordinary enforcement powers in parallel. A safety incident between the confidential filing and a roadshow is both an operating risk and a potential trigger for the offices that cleared the recap.
• Unfinished Musk litigation. The conversion case is won at trial on limitations, with appeal threatened and Phase II antitrust still open, plus the Texas Apple-integration case. None of these currently blocks a listing. All of them belong in “legal proceedings,” and a plaintiff with Musk’s resources can keep them alive through a lockup.
• Public-company plumbing and the safety narrative. Management has itself cited safety obligations and reporting readiness—not the nonprofit charter—as the reason not to list in 2026. The structure made an IPO legally available. It did not make the governance story simple enough, or the loss-making infrastructure plan steady enough, that management has been willing to price it.

For someone allocating to the eventual listing, the restructuring’s real trade is this: investor rights are now conventional on economics (uncapped, pro rata common, no profit ceiling) and unconventional on power (no board control, mission-first safety votes, a perpetual related-party contract with the largest outside shareholder, and two state AGs as standing monitors). The October 2025 recap and the April 2026 Microsoft amendment removed the obstacles that made an IPO structurally impossible. They replaced them with a governance regime that public markets can buy—only if the discount for control, safety override, and the Microsoft annuity is explicit in the price.

---

Recent Findings Supplement (October 2026)

OpenAI completed its recapitalization on October 28, 2025, converting its for-profit arm into OpenAI Group PBC (a public benefit corporation) while the renamed OpenAI Foundation (nonprofit) retains sole board control and now holds direct equity.[1][2]

Post-April 22, 2026 developments center on refinements to the Microsoft partnership, resolution of key litigation, ongoing Foundation activities, and IPO preparations, with no major new regulatory actions or structural changes reported.

Microsoft’s stake and revised agreement (April 27, 2026 amendment): Microsoft remains the largest disclosed outside shareholder. Its stake stood at roughly 27% (as-converted diluted, ~$135 billion value at the time) immediately after the October 2025 recap and was approximately 25% on an as-converted basis per its fiscal 2026 10-K (year ended June 30, 2026).[3][3]

The April 2026 amendment provides OpenAI greater flexibility: products can now be served on any cloud (Azure remains primary unless Microsoft cannot or chooses not to support capabilities); Microsoft’s IP license for models/products is non-exclusive through 2032 (previously more exclusive, with AGI-linked elements); OpenAI’s revenue-share payments to Microsoft continue through 2030 at the same percentage but subject to a total cap (Microsoft no longer pays a revenue share to OpenAI); and the AGI clause is removed, with any AGI declaration now verified by an independent expert panel.[4][5]

This loosens prior exclusivity constraints, supports OpenAI’s multi-cloud strategy and revenue diversification, reduces dependency risks for investors, and enhances IPO readiness by clarifying long-term economics and governance separation while preserving Microsoft’s significant equity participation and cloud relationship.[6]

OpenAI Foundation’s stake and activities: The Foundation holds a 26% equity stake in OpenAI Group PBC (plus a warrant for additional shares if valuation milestones are met, such as a >10x increase over 15 years), valued at approximately $130 billion based on the ~$500 billion valuation at the time of the recap (implying a total Group valuation around that level; later rounds have pushed higher valuations, e.g., $852 billion in March 2026).[2][7]

It retains sole power to appoint and remove PBC directors and prioritizes the shared mission (AGI benefiting humanity) in governance, including safety/security decisions where directors must consider the mission (with Foundation oversight via its Safety and Security Committee, including potential halts on model releases).[3]

In 2026 updates, the Foundation has advanced philanthropic efforts, including launching applications for the first wave of a $50 million People-First AI Fund (supporting AI literacy, community innovation, and economic opportunity) and initial $25 billion commitments focused on health/disease cures and AI resilience/technical risk mitigation.[8][9]

This equity alignment ties the nonprofit’s resources directly to PBC success, strengthening mission-driven governance without diluting control and positioning the Foundation as a major long-term beneficiary, which supports stable investor rights and mission-aligned IPO narratives.[2]

Regulatory approvals (Delaware and California Attorneys General): The restructuring was completed after nearly a year of dialogue, with Delaware issuing a Statement of No Objection on October 28, 2025, and both AG offices securing concessions (reported as ~20 in total via MOUs/Statements). No new approvals, modifications, or enforcement actions are detailed in post-April 2026 sources.[3][10]

The structure incorporates mission requirements in the PBC’s charter and enhanced oversight, reducing prior legal risks and bolstering governance credibility for IPO processes. Ongoing compliance (e.g., board transitions) is noted in watchdog updates but without reported issues.[11]

Litigation (including Musk v. OpenAI): The primary Musk lawsuit (challenging the for-profit conversion/breach of charitable trust, unjust enrichment, etc.) went to trial in April–May 2026. On May 18, 2026, a unanimous advisory jury found the claims barred by the statute of limitations (deliberations under two hours); the judge adopted the verdict and dismissed the case. Musk’s counsel indicated an intent to appeal, but the outcome removes an immediate threat to the structure.[12][13]

Related matters, such as xAI’s trade secrets suit against OpenAI, were dismissed (final dismissal without leave to amend around June 2026, with OpenAI prevailing on key points; fee disputes followed into October 2026).[14]

Resolution of these cases clears a major overhang, improving IPO readiness by reducing litigation uncertainty and governance risks, though any appeal could introduce residual noise. No other major obstacles to the restructuring are highlighted in recent coverage.

IPO readiness, governance, and investor rights implications: The PBC structure (conventional equity replacing capped-profit, mission baked into bylaws) combined with Foundation control enables capital raising, talent attraction via uncapped upside, and proportional investor participation in value growth while embedding stakeholder/mission considerations.[15]

OpenAI confidentially submitted an S-1 in June 2026 (targeting potentially 2027 listing per Altman and CFO comments citing safety priorities and public-company readiness); it is actively fundraising (e.g., reported ~$30 billion round talks at ~$1.4 trillion valuation in October 2026, building on the $852 billion March 2026 round).[16][17]

Governance features (independent Foundation board with mission oversight, PBC stakeholder duties especially on safety) provide stronger mission alignment than a standard corporation, appealing to certain investors while satisfying regulators. Investor rights benefit from clearer economics post-Microsoft amendments and equity participation, though the Foundation’s control and PBC obligations introduce mission-based guardrails. Remaining considerations include any Musk appeal outcomes and sustained AG compliance, but the overall framework positions OpenAI for a scaled public listing with retained nonprofit influence.[18]

Sources primarily include OpenAI’s official October 2025/2026 statements and structure page, Microsoft disclosures, court reporting on the Musk verdict (e.g., WSJ, Law360), FourWeekMBA ownership analysis (October 2026), and contemporaneous coverage of the April 2026 Microsoft amendment (e.g., NYT, FT, Verge). No contradictory post-recap regulatory shifts or new major obstacles appear in sources after April 22, 2026.